Search results for "Renal physiology"

showing 10 items of 26 documents

Increased Symmetric Dimethylarginine Level Is Associated with Worse Hospital Outcomes through Altered Left Ventricular Ejection Fraction in Patients …

2017

International audience; Objectives: We aimed to investigate whether SDMA-symmetric dimethylarginine-the symmetrical stereoisomer of ADMA-might be a marker of left ventricular function in AMI.Background: Asymmetric dimethylarginine (ADMA) has been implicated in the prognosis after acute myocardial infarction (AMI) and heart failure (HF).Methods: Cross sectional prospective study from 487 consecutive patients hospitalized 2, and death.Results: Patients were analysed based on SDMA tertiles. Sex, diabetes, dyslipidemia, and prior MI were similar for all tertiles. In contrast, age and hypertension increased across the tertiles (p<0.001). From the first to the last tertile, GRACE risk score was e…

0301 basic medicineMalePhysiologyPerformanceMyocardial Infarctionlcsh:MedicineBlood PressureChronic Heart-Failure030204 cardiovascular system & hematologyVascular MedicineBiochemistryVentricular Function Leftchemistry.chemical_compound0302 clinical medicineChronic Kidney DiseaseMedicine and Health SciencesCoronary Heart DiseaseDiseaseMyocardial infarctionProspective cohort studylcsh:ScienceMultidisciplinaryFramingham Risk ScoreEjection fractionAsymmetric DimethylarginineNeurochemistryMiddle AgedMetaanalysis[ SDV.MHEP.CSC ] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemPrognosisArteryHospitals3. Good healthTreatment OutcomeImpactNephrologyHypertensionCardiologyFemaleAnatomyNeurochemicalsResearch ArticleGlomerular Filtration Ratemedicine.medical_specialtyCardiologyRenal functionNitric OxideArginine03 medical and health sciences[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemInternal medicinemedicineHumansRenal Insufficiency ChronicMortalityAgedHeart FailureRenal Physiologybusiness.industrylcsh:RBiology and Life SciencesRenal SystemMarkermedicine.diseaseRenal-Function030104 developmental biologychemistryHeart failurelcsh:QAsymmetric dimethylargininebusinessDyslipidemiaNeuroscience
researchProduct

PO-002 Angiotensin II-induced hypertension increases the mutation frequency in the rat kidney

2018

Introduction Epidemiological studies revealed an increased risk for kidney cancer in hypertensive patients. In many of these patients, the blood pressure regulating renin angiotensin aldosterone system (RAAS) is activated. A stimulated RAAS can lead to oxidative stress and DNA damage, as we have shown both in vitro and in animal models of hypertension. Here, we used a rat model to quantify mutations generated by 20 weeks of angiotensin II-infusion. Material and methods BigBlue+/- rats, which carry a transgenic lacI gene for mutation analysis, were treated with 0.4 mg angiotensin II/kg/day with the help of osmotic minipumps. Urinary samples were collected in week 15 by placing the rats into …

Cancer ResearchKidneymedicine.medical_specialtyDNA damagebusiness.industryUrinary systemmedicine.disease_causeAngiotensin IImedicine.anatomical_structureEndocrinologyOncologyInternal medicineRenal physiologyRenin–angiotensin systemmedicineMutation frequencybusinessOxidative stressESMO Open
researchProduct

Renal and nonrenal clearances of ceftriaxone at the steady-state and its relation to plasma protein binding

1995

Abstract The effect of the saturable plasma protein binding of ceftriaxone on the elimination of this drug was studied under steady-state conditions in the rat. A concentration-dependent increase in the total, renal and nonrenal clearances of total drug (bound + unbound) was observed, and it was related to the increase in the ex vivo unbound fraction of ceftriaxone as the plasma concentration increased. The nonrenal clearance of the unbound ceftriaxone showed a statistically significant decrease as the plasma concentration of the unbound drug at the steady state increased, which indicates that the nonrenal elimination of the drug (mainly by biliary excretion) is a saturable process. Renal c…

Kidneymedicine.medical_specialtyChemistryPharmaceutical ScienceRenal functionmedicine.anatomical_structureEndocrinologyPharmacokineticsRenal physiologyInternal medicineBlood plasmamedicineCeftriaxoneSteady state (chemistry)medicine.drugAntibacterial agentEuropean Journal of Pharmaceutical Sciences
researchProduct

GDF-15 predicts cardiovascular events in acute chest pain patients

2017

Background Treatment of patients presenting with possible acute myocardial infarction (AMI) is based on timely diagnosis and proper risk stratification aided by biomarkers. We aimed at evaluating the predictive value of GDF-15 in patients presenting with symptoms suggestive of AMI. Methods Consecutive patients presenting with suspected AMI were enrolled in three study centers. Cardiovascular events were assessed during a follow-up period of 6 months with a combined endpoint of death or MI. Results From the 1818 enrolled patients (m/f = 1208/610), 413 (22.7%) had an acute MI and 63 patients reached the combined endpoint. Patients with MI and patients with adverse outcome had higher GDF-15 le…

MalePhysiologyPeptide HormonesMyocardial InfarctionSocial Scienceslcsh:MedicineKaplan-Meier Estimate030204 cardiovascular system & hematologyChest painSeverity of Illness IndexBiochemistryVascular Medicine0302 clinical medicineRisk FactorsMedicine and Health SciencesCoronary Heart Disease030212 general & internal medicineMyocardial infarctionlcsh:ScienceMultidisciplinarybiologyHazard ratioMiddle AgedTroponinLipoproteins LDLAcute DiseaseFemalemedicine.symptomLipoproteins HDLResearch ArticleGlomerular Filtration Ratemedicine.medical_specialtyChest PainGrowth Differentiation Factor 15LipoproteinsCardiologyRenal functionPhonology03 medical and health sciencesNatriuretic PeptideInternal medicineSeverity of illnessmedicineHumansSyntaxddc:610AgedProportional Hazards ModelsRenal PhysiologyProportional hazards modelbusiness.industryTroponin Ilcsh:RBiology and Life SciencesProteinsLinguisticsmedicine.diseaseTroponinHormonesSurgeryCytoskeletal Proteinsbiology.proteinlcsh:QGDF15businessBiomarkers
researchProduct

Cardiac and renal dysfunction is associated with progressive hearing loss in patients with Fabry disease.

2017

Background Fabry disease (FD) is an X-linked recessive hereditary lysosomal storage disorder which results in the accumulation of globotriaosylceramid (Gb3) in tissues of kidney and heart as well as central and peripheral nervous system. Besides prominent renal and cardiac organ involvement, cochlear symptoms like high-frequency hearing loss and tinnitus are frequently found with yet no comprehensive data available in the literature. Objective To examine hearing loss in patients with FD depending on cardiac and renal function. Material and methods Single-center study with 68 FD patients enrolled between 2012 and 2016 at the Department of Oto-Rhino-Laryngology, Plastic, Aesthetic and Reconst…

MalePhysiologylcsh:MedicineOtology030204 cardiovascular system & hematologyDeafnessKidneyCardiovascular PhysiologyTinnitus0302 clinical medicineQuality of lifeMedicine and Health Scienceslcsh:ScienceHearing DisordersKidneySex CharacteristicsMultidisciplinaryEarHeartAudiologyMiddle Agedmedicine.anatomical_structureNeurologyCohortCardiologySensorineural hearing lossFemalemedicine.symptomAnatomyGlomerular Filtration RateResearch ArticleAdultmedicine.medical_specialtyHearing lossHearing Loss SensorineuralRenal function03 medical and health sciencesInternal medicinemedicineotorhinolaryngologic diseasesHumansddc:610AgedRenal Physiologybusiness.industrylcsh:RBiology and Life SciencesKidneysRenal Systemmedicine.diseaseFabry diseaseOtorhinolaryngologyEarsQuality of LifeFabry Diseaselcsh:QbusinessHead030217 neurology & neurosurgeryTinnitusPloS one
researchProduct

Transforming growth factor β1 and additional renoprotective effect of combination ACE inhibitor and angiotensin II receptor blocker in hypertensive s…

2005

Objective To verify the benefit of renin–angiotensin system blockade in hypertension, the effects of 24 weeks’ losartan and ramipril treatment, both alone and in combination, on urinary albumin excretion (UAE) and circulating transforming growth factor b1 (TGFb1) have been evaluated in hypertensive subjects with minor renal abnormalities. Design and methods Fifty-one patients with stage 1 and 2 essential hypertension and with UAE &gt;—20 mg/24 h but with maintained renal function have been included. After a 4-week run-in with placebo administration, a randomized double-blind, three-arm double-dummy trial was used. All the hypertensives (HT) were allocated randomly to three treatment arms (1…

MaleRamiprilmedicine.medical_specialtyAngiotensin receptorHypertension RenalPhysiologyAngiotensin-Converting Enzyme InhibitorsPharmacologyKidneySeverity of Illness IndexLosartanAce-inhibitors Angiotensin II receptor blockers hypertensive renal disease transforming growth factor β1.Transforming Growth Factor beta1transforming growth factor b1RamiprilTransforming Growth Factor betaInternal medicineInternal MedicinemedicineHumansRenal Insufficiencybusiness.industryMiddle AgedAngiotensin IIBlockadeangiotensin II receptor blockerEndocrinologyLosartanhypertensive renal diseaseRenal physiologyACE inhibitorDrug Therapy CombinationFemaleCardiology and Cardiovascular Medicinebusinessangiotensin-converting enzyme-inhibitorAngiotensin II Type 1 Receptor BlockersBiomarkersTransforming growth factormedicine.drug
researchProduct

Effect of mountain ultramarathon distance competition on biochemical variables, respiratory and lower-limb fatigue

2020

The study aimed at assessing the acute physiological effects of running a 65-km vs a 107- km mountain ultramarathon. Nineteen athletes (15 males and 4 females) from the shorter race and forty three athletes (26 males and 17 females) from the longer race were enrolled. Body weight, respiratory and lower limb strength were assessed before and after the race. Blood samples were obtained before, after and 24-h post-race. Body weight loss did not differ between races. A decrease in squat jump height (p<0.01; d = 1.4), forced vital capacity (p<0.01; d = 0.5), forced expiratory volume in 1 s (p<0.01; d = 0.6), peak inspiratory flow (p<0.01; d = 0.6) and maximal inspiratory pressure (p<0.01; d = 0.…

MaleVital capacityPhysiologyVital CapacitySocial Sciences030204 cardiovascular system & hematologyBiochemistryRunning0302 clinical medicineForced Expiratory VolumeMedicine and Health SciencesPsychologyRespiratory systemCreatine KinaseLungImmune ResponseMusculoskeletal SystemFatiguemeasurement_unitMultidisciplinarybiologyMusclesQRSports ScienceTroponinRespiratory Function TestsCorredors (Esports)Lower ExtremityCreatininemeasurement_unit.measuring_instrumentCardiologyMedicineFemaleAnatomyResearch ArticleSportsGlomerular Filtration RateAdultmedicine.medical_specialtyScienceImmunologyRenal functionBody weightLower limb03 medical and health sciencesSigns and SymptomsInternal medicinemedicineHumansMuscle StrengthPeak flow meterCardiac MusclesInflammationBehaviorRenal Physiologybusiness.industryBiological LocomotionBiology and Life SciencesProteins030229 sport sciencesRenal SystemTroponinCytoskeletal ProteinsAthletesPulmonsbiology.proteinPhysical EnduranceRecreationCreatine kinaseClinical MedicinebusinessBiomarkers
researchProduct

Effect of L-thyroxine on renal excretion of water and electrolytes in both normal and mercury-intoxicated rats.

1980

The urine output and the change in excretion of electrolytes (sodium, potassium, calcium, chloride, inorganic phosphate) in rats following mercury-induced acute tubular lesions showed marked recovery during L-thyroxine therapy. The kidney mechanisms responsible for this effect are discussed, considering especially the observation that rats treated with L-thyroxine have a reduced urinary output, unlike other species, including man, which react with polyuria. The oliguric effect of thyroid hormone in rats is attributed to the greater length of the vasa recta and loops of Henle.

Malemedicine.medical_specialtyKidneyurogenital systemChemistryUrologySodiumchemistry.chemical_elementDiuresisVasa rectaCalciumWater-Electrolyte BalanceRatsExcretionThyroxineEndocrinologymedicine.anatomical_structurePolyuriaInternal medicineRenal physiologyMercury PoisoningmedicineAnimalsmedicine.symptomUrological research
researchProduct

Disposition of acamprosate in the rat: Influence of probenecid

2002

The purpose of the present study was to investigate the disposition of acamprosate (calcium bis acetyl-homotaurine) in the rat. Initially, we studied the linearity of acamprosate disposition and the fraction of acamprosate excreted unchanged in the urine of the animals. Rats received 9.3, 36.6 or 73.3 mg/kg of the drug as an intravenous bolus. The statistical analysis of the pharmacokinetic parameters did not reveal any significant difference, indicating that acamprosate disposition was linear within the range of the doses assayed. On average, 95% of the administered dose was excreted unchanged in the urine of the animals in the 0-6 h post-administration period indicating that renal excreti…

Malemedicine.medical_specialtyMetabolic Clearance RateTaurineAcamprosatePharmaceutical ScienceRenal functionUrinePharmacologyPharmacokineticsInternal medicinemedicineAnimalsDrug InteractionsPharmacology (medical)Rats WistarPharmacologyKidneyProbenecidChemistryGeneral MedicineDrug interactionRatsProbenecidEndocrinologymedicine.anatomical_structureAcamprosateRenal physiologyInjections Intravenousmedicine.drugBiopharmaceutics &amp; Drug Disposition
researchProduct

Plasma neutrophil gelatinase-associated lipocalin and long-term mortality in patients with acute heart failure and normal renal function

2015

Neutrophil gelatinase-associated lipocalin (NGAL) has emerged as a renal tubular marker for early renal dysfunction [1]. Recent studies highlighted its role in predicting acute kidney injury (AKI) and clinical outcomes in a wide range of cardiovascular diseases [2], [3], [4] and [5]. However, in heart failure (HF), conflicting results have been reported [4], [5], [6] and [7] and some ambiguities still prevail about the prognostic utility of NGAL beyond standard prognosticators and traditional renal biomarkers. We aimed to evaluate the independent ability of serum NGAL for predicting long-term mortality in patients admitted for acute HF (AHF). We prospectively enrolled 206 patients consecuti…

Malemedicine.medical_specialtyRenal function030204 cardiovascular system & hematologyKidneyKidney Function TestsGastroenterology03 medical and health sciencesNormal renal function0302 clinical medicineText miningLipocalin-2Risk FactorsInternal medicinemedicineHumansIn patient030212 general & internal medicineProspective StudiesMortalityProspective cohort studyAgedAged 80 and overHeart Failurebusiness.industryPlasma neutrophilAcute heart failureMiddle Agedmedicine.diseasePrognosisNeutrophil gelatinase-associated lipocalinHeart failureRenal physiologyFemaleCardiology and Cardiovascular MedicinebusinessBiomarkersRenal function
researchProduct